IDYA logo

IDEAYA Biosciences (IDYA) Company Overview

Profile

Full Name:

IDEAYA Biosciences, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

May 23, 2019

Indexes:

Not included

Description:

IDEAYA Biosciences is a biotechnology company focused on developing targeted therapies for cancer. They aim to create innovative treatments by understanding the genetic and molecular basis of diseases. Their work involves research, drug development, and collaboration with other organizations to improve patient outcomes in oncology.

Events Calendar

Earnings

Next earnings date:

May 7, 2025

Recent quarterly earnings:

Feb 13, 2025

Recent annual earnings:

Feb 13, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 14, 25 Stephens & Co.
Overweight
Jan 15, 25 RBC Capital
Outperform
Jan 13, 25 Cantor Fitzgerald
Overweight
Dec 17, 24 Wedbush
Outperform
Dec 17, 24 Cantor Fitzgerald
Overweight
Nov 18, 24 Stephens & Co.
Overweight
Nov 5, 24 Leerink Partners
Market Perform
Oct 29, 24 Oppenheimer
Outperform
Oct 24, 24 UBS
Buy
Sep 24, 24 Wedbush
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for IDEAYA Biosciences?
  • Does IDEAYA Biosciences pay dividends?
  • What sector is IDEAYA Biosciences in?
  • What industry is IDEAYA Biosciences in?
  • What country is IDEAYA Biosciences based in?
  • When did IDEAYA Biosciences go public?
  • Is IDEAYA Biosciences in the S&P 500?
  • Is IDEAYA Biosciences in the NASDAQ 100?
  • Is IDEAYA Biosciences in the Dow Jones?
  • When was IDEAYA Biosciences's last earnings report?
  • When does IDEAYA Biosciences report earnings?
  • Should I buy IDEAYA Biosciences stock now?

What is the ticker symbol for IDEAYA Biosciences?

The ticker symbol for IDEAYA Biosciences is NASDAQ:IDYA

Does IDEAYA Biosciences pay dividends?

No, IDEAYA Biosciences does not pay dividends

What sector is IDEAYA Biosciences in?

IDEAYA Biosciences is in the Healthcare sector

What industry is IDEAYA Biosciences in?

IDEAYA Biosciences is in the Biotechnology industry

What country is IDEAYA Biosciences based in?

IDEAYA Biosciences is headquartered in United States

When did IDEAYA Biosciences go public?

IDEAYA Biosciences's initial public offering (IPO) was on May 23, 2019

Is IDEAYA Biosciences in the S&P 500?

No, IDEAYA Biosciences is not included in the S&P 500 index

Is IDEAYA Biosciences in the NASDAQ 100?

No, IDEAYA Biosciences is not included in the NASDAQ 100 index

Is IDEAYA Biosciences in the Dow Jones?

No, IDEAYA Biosciences is not included in the Dow Jones index

When was IDEAYA Biosciences's last earnings report?

IDEAYA Biosciences's most recent earnings report was on Feb 13, 2025

When does IDEAYA Biosciences report earnings?

The next expected earnings date for IDEAYA Biosciences is May 7, 2025

Should I buy IDEAYA Biosciences stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions